-+ 0.00%
-+ 0.00%
-+ 0.00%

PRELUDE THERAPEUTICS INCORPORATED - MAINTAINS FULL GLOBAL DEVELOPMENT AND COMMERCIAL RIGHTS TO PRT13722

Reuters·10/13/2026 11:03:08